m
Recent Posts
Connect with:
Thursday / April 22.
HomeminewsGreen Partners: Thélios, Eastman, Mazzucchelli 1849

Green Partners: Thélios, Eastman, Mazzucchelli 1849

Thélios has joined forces with acetate-sheet manufacturer Mazzucchelli 1849 and Eastman – a pioneer in molecular recycling – to advance sustainable innovation in the eyewear industry.

Carlo Roni, R&D Director of Thélios said, “Sustainability has become a business imperative. We have chosen to team up with the best in class players – Mazzucchelli for acetate transformation and Eastman for molecular recycling – to work jointly on the development of new sustainable materials, which we hope will drive change in our industry.”

The three entities say they are working jointly on the release of acetate eyewear frames which will be “significantly more sustainable than the current offer”.

“This project is part of a sustainability path that Mazzucchelli has been pursuing for several years. We believe in sustainability and we are proud to be part of this virtuous cycle together with Eastman and Thélios,” said Giovanni Orsi Mazzucchelli, Chairman and shareholder of Mazzucchelli 1849. “It is thanks to the commitment of each individual player that it will be possible to achieve a full sustainable transformation of the eyewear industry.”

With the aim to limit the environmental impact of acetate frames to a minimum, the partners are jointly exploring a series of eco-responsible formulas, using certified recycled content and biosourced materials.

Based on Eastman Acetate Renew, these new formulas will match both the technical and aesthetic qualities of traditional acetates, while being highly sustainable.

The first collections are planned for release by Thélios in 2022.

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.